TransCure bioServices SAS

TransCure bioServices (TCS) SAS is a service company, spin-off from the Universities of Geneva, Zürich, and Pretoria. TCS provides its unique, predictive, preclinical Research & Development (R&D) expertise via its services to the pharmaceutical and biotechnology industry. Transcure offers humanized in vivo pharmacology and mouse models, with reconstituted immune system (HIS), liver (huLIV), pancreas or skin, immuno- tox as fee-for-services to customers. Our expertise helps the client to select the most safe and effective therapies that target the immune system, liver, pancreas or skin diseases. Several anti-infectious platforms such as HIV, HBV, HCV, CMV, malaria, Dengue or non-infectious diseases like cancers, auto-immune, inflammatory (IBD), RA, but also immotoxicology studies are offered to our clients.